Matinas BioPharma Holdings (MTNB) Cash from Financing Activities (2013 - 2025)
Matinas BioPharma Holdings (MTNB) posted Cash from Financing Activities of $58,000 for Q4 2025, compared with -$1,000 a year earlier and down 9.4% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Cash from Financing Activities (2013 - 2025) Analysis & Trends
For FY2025, Matinas BioPharma Holdings' Cash from Financing Activities came in at $3.39 million, down 63.0% from FY2024.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of -41.2% (FY2020 to FY2025).
- In prior years, Matinas BioPharma Holdings' Cash from Financing Activities was $9.17 million in FY2024, -$7,000 in FY2023, $79,000 in FY2022 (-98.9%) and $6.97 million in FY2021 (-85.5%).
- Quarterly Cash from Financing Activities has run from a low of -$67,000 in Q3 2024 to a high of $9.19 million in Q2 2024 over five years.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was $64,000 (Q3 2025), $1.62 million (Q2 2025) and $1.65 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Matinas BioPharma Holdings | 16.34 Mn | 3.74 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 58,000.00 |
| Sep 30, 2025 | 64,000.00 |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | -67,000.00 |
| Jun 30, 2024 | 9.19 Mn |
| Mar 31, 2024 | 53,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2022 | -5,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Jun 30, 2022 | -6,000.00 |
| Mar 31, 2022 | 93,000.00 |
| Dec 31, 2021 | 8,330.00 |
| Sep 30, 2021 | -8,324.00 |
| Jun 30, 2021 | 180,478.00 |
| Mar 31, 2021 | 6.78 Mn |
API Access
Matinas BioPharma Holdings Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();